{"transactions":[{"id":1129033,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79070,"kind":"person","name":"COLLERAN LISA N","position":1,"cik":"0001212312","reported_name":"COLLERAN LISA N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-30T16:14:50.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":11700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests on the earlier of (a) May 28, 2026, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":11700,"derivative":{"exercise_price":1.39,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":11700},"source":{"system":"sec-edgar","filing":"0001062993-25-010569","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1212312/000106299325010569/form4.xml","form_type":"4"}},{"id":1129032,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79070,"kind":"person","name":"COLLERAN LISA N","position":1,"cik":"0001212312","reported_name":"COLLERAN LISA N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-30T16:14:50.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":7950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest on the earlier of (a) May 28, 2026, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":18470,"source":{"system":"sec-edgar","filing":"0001062993-25-010569","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212312/000106299325010569/form4.xml","form_type":"4"}},{"id":1488178,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79070,"kind":"person","name":"COLLERAN LISA N","position":1,"cik":"0001212312","reported_name":"COLLERAN LISA N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T17:00:21.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":6200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests on the earlier of (a) June 4, 2025, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":6200,"derivative":{"exercise_price":5.71,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":6200},"source":{"system":"sec-edgar","filing":"0001062993-24-012090","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1212312/000106299324012090/form4.xml","form_type":"4"}},{"id":1488177,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79070,"kind":"person","name":"COLLERAN LISA N","position":1,"cik":"0001212312","reported_name":"COLLERAN LISA N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T17:00:21.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":4250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest on the earlier of (a) June 4, 2025, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":10520,"source":{"system":"sec-edgar","filing":"0001062993-24-012090","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212312/000106299324012090/form4.xml","form_type":"4"}},{"id":1869307,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79070,"kind":"person","name":"COLLERAN LISA N","position":1,"cik":"0001212312","reported_name":"COLLERAN LISA N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-02T16:38:44.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":5360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":5360,"derivative":{"exercise_price":10.34,"expiration_date":"2033-06-01","underlying":"Common Stock","underlying_shares":5360},"source":{"system":"sec-edgar","filing":"0001062993-23-012778","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1212312/000106299323012778/form4.xml","form_type":"4"}},{"id":1869306,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79070,"kind":"person","name":"COLLERAN LISA N","position":1,"cik":"0001212312","reported_name":"COLLERAN LISA N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T16:38:44.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":3135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":6270,"source":{"system":"sec-edgar","filing":"0001062993-23-012778","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212312/000106299323012778/form4.xml","form_type":"4"}},{"id":2224174,"issuer":{"id":4473,"kind":"organization","name":"ESTABLISHMENT LABS HOLDINGS INC."},"owners":[{"id":79070,"kind":"person","name":"COLLERAN LISA N","position":1,"cik":"0001212312","reported_name":"COLLERAN LISA N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-06-22T20:04:10.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":2345,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an award of stock units under the Issuer's 2018 Equity Incentive Plan. The shares subject to the award vest in full on the earlier of June 17, 2023 or the day prior to the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through such date."}],"balance_after":45276,"source":{"system":"sec-edgar","filing":"0001688757-22-000068","document":"wf-form4_165592822769455.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1688757/000168875722000068/wf-form4_165592822769455.xml","form_type":"4"}},{"id":2247152,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79070,"kind":"person","name":"COLLERAN LISA N","position":1,"cik":"0001212312","reported_name":"COLLERAN LISA N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-02T16:06:02.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":5360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests on the earlier of (a) June 1, 2023, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Peron's continued service through the applicable vesting date."}],"balance_after":5360,"derivative":{"exercise_price":6.84,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":5360},"source":{"system":"sec-edgar","filing":"0001062993-22-014128","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1212312/000106299322014128/form4.xml","form_type":"4"}},{"id":2247151,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79070,"kind":"person","name":"COLLERAN LISA N","position":1,"cik":"0001212312","reported_name":"COLLERAN LISA N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-02T16:06:02.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":3135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest on the earlier of (a) June 1, 2023, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Peron's continued service through the applicable vesting date."}],"balance_after":3135,"source":{"system":"sec-edgar","filing":"0001062993-22-014128","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212312/000106299322014128/form4.xml","form_type":"4"}},{"id":2680643,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79070,"kind":"person","name":"COLLERAN LISA N","position":1,"cik":"0001212312","reported_name":"COLLERAN LISA N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-04T16:56:33.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":10825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of (a) June 2, 2022, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":10825,"derivative":{"exercise_price":13.16,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":10825},"source":{"system":"sec-edgar","filing":"0001192482-21-000491","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212312/000119248221000491/edgar.xml","form_type":"4"}},{"id":2695292,"issuer":{"id":4473,"kind":"organization","name":"ESTABLISHMENT LABS HOLDINGS INC."},"owners":[{"id":79070,"kind":"person","name":"COLLERAN LISA N","position":1,"cik":"0001212312","reported_name":"COLLERAN LISA N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2021-05-26T20:34:48.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in full on the earlier of May 25, 2022 or the day prior to the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through such date."}],"balance_after":10000,"derivative":{"exercise_price":78.11,"expiration_date":"2031-05-25","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001628280-21-011123","document":"wf-form4_162206127166423.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1688757/000162828021011123/wf-form4_162206127166423.xml","form_type":"4"}},{"id":3118337,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79070,"kind":"person","name":"COLLERAN LISA N","position":1,"cik":"0001212312","reported_name":"COLLERAN LISA N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-08T16:39:42.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":8806,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of (a) the first anniversary of June 4, 2020, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's 2019 Equity Incentive Plan), subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":8806,"derivative":{"exercise_price":17,"expiration_date":"2030-06-04","underlying":"Common Stock","underlying_shares":8806},"source":{"system":"sec-edgar","filing":"0001192482-20-000452","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212312/000119248220000452/edgar.xml","form_type":"4"}},{"id":3133842,"issuer":{"id":4473,"kind":"organization","name":"ESTABLISHMENT LABS HOLDINGS INC."},"owners":[{"id":79070,"kind":"person","name":"COLLERAN LISA N","position":1,"cik":"0001212312","reported_name":"COLLERAN LISA N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2020-05-27T20:44:38.000Z","date":"2020-05-26","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest in full on the earlier of May 26, 2021 or the day prior to the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through such date."}],"balance_after":10000,"derivative":{"exercise_price":18.14,"expiration_date":"2030-05-26","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001628280-20-008468","document":"wf-form4_159061226053183.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1688757/000162828020008468/wf-form4_159061226053183.xml","form_type":"4"}},{"id":3133841,"issuer":{"id":4473,"kind":"organization","name":"ESTABLISHMENT LABS HOLDINGS INC."},"owners":[{"id":79070,"kind":"person","name":"COLLERAN LISA N","position":1,"cik":"0001212312","reported_name":"COLLERAN LISA N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-05-27T20:44:38.000Z","date":"2020-05-22","kind":"purchase","acquired":true,"shares":1165,"price":17.8325,"value":20774.8625,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $17.78 to $17.8399 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":42931,"source":{"system":"sec-edgar","filing":"0001628280-20-008468","document":"wf-form4_159061226053183.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1688757/000162828020008468/wf-form4_159061226053183.xml","form_type":"4"}},{"id":3171661,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79070,"kind":"person","name":"COLLERAN LISA N","position":1,"cik":"0001212312","reported_name":"COLLERAN LISA N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-22T20:43:41.000Z","date":"2020-04-20","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 36 equal monthly installments on each monthly anniversary of April 20, 2020, subject to the Reporting Person's continuous service with the Issuer."}],"balance_after":8000,"derivative":{"exercise_price":8.42,"expiration_date":"2030-04-20","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001192482-20-000302","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1212312/000119248220000302/edgar.xml","form_type":"4"}},{"id":3393713,"issuer":{"id":4473,"kind":"organization","name":"ESTABLISHMENT LABS HOLDINGS INC."},"owners":[{"id":79070,"kind":"person","name":"COLLERAN LISA N","position":1,"cik":"0001212312","reported_name":"COLLERAN LISA N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-10-15T23:05:46.000Z","date":"2019-09-04","kind":"purchase","acquired":true,"shares":535,"price":19.13,"value":10234.55,"ownership":{"direct":true},"balance_after":41766,"source":{"system":"sec-edgar","filing":"0001628280-19-012295","document":"wf-form4_157118071876235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1688757/000162828019012295/wf-form4_157118071876235.xml","form_type":"4"}},{"id":3393712,"issuer":{"id":4473,"kind":"organization","name":"ESTABLISHMENT LABS HOLDINGS INC."},"owners":[{"id":79070,"kind":"person","name":"COLLERAN LISA N","position":1,"cik":"0001212312","reported_name":"COLLERAN LISA N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-10-15T23:05:46.000Z","date":"2019-05-23","kind":"purchase","acquired":true,"shares":2300,"price":21.81,"value":50163.0,"ownership":{"direct":true},"balance_after":41231,"source":{"system":"sec-edgar","filing":"0001628280-19-012295","document":"wf-form4_157118071876235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1688757/000162828019012295/wf-form4_157118071876235.xml","form_type":"4"}},{"id":3496060,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":79070,"kind":"person","name":"COLLERAN LISA N","position":1,"cik":"0001212312","reported_name":"COLLERAN LISA N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-10T23:12:44.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":22461,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22461,"derivative":{"exercise_price":4.15,"exercise_date":"2020-06-06","expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":22461},"source":{"system":"sec-edgar","filing":"0001104659-19-034645","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000110465919034645/a4.xml","form_type":"4"}},{"id":3496059,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":79070,"kind":"person","name":"COLLERAN LISA N","position":1,"cik":"0001212312","reported_name":"COLLERAN LISA N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-10T23:12:44.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":18674,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units vest on June 6, 2020."}],"balance_after":18674,"source":{"system":"sec-edgar","filing":"0001104659-19-034645","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000110465919034645/a4.xml","form_type":"4"}},{"id":3500723,"issuer":{"id":4473,"kind":"organization","name":"ESTABLISHMENT LABS HOLDINGS INC."},"owners":[{"id":79070,"kind":"person","name":"COLLERAN LISA N","position":1,"cik":"0001212312","reported_name":"COLLERAN LISA N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2019-06-05T20:38:55.000Z","date":"2019-06-03","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in full on the earlier of June 3, 2020 or the day prior to the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through such date."}],"balance_after":10000,"derivative":{"exercise_price":23.05,"expiration_date":"2029-06-03","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001628280-19-007592","document":"wf-form4_155976709945827.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1688757/000162828019007592/wf-form4_155976709945827.xml","form_type":"4"}},{"id":3862902,"issuer":{"id":4473,"kind":"organization","name":"ESTABLISHMENT LABS HOLDINGS INC."},"owners":[{"id":79070,"kind":"person","name":"COLLERAN LISA N","position":1,"cik":"0001212312","reported_name":"COLLERAN LISA N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class C Ordinary Shares","published_at":"2018-07-23T20:28:22.000Z","date":"2018-07-23","kind":"exercise","acquired":false,"shares":26232,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Class A Ordinary Shares automatically converted into Common Shares on a one-for-one basis upon the closing of the Issuer's initial public offering of Common Shares and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Class A Ordinary Shares automatically converted into Common Shares on a one-for-one basis upon the closing of the Issuer's initial public offering of Common Shares and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Class A Ordinary Shares automatically converted into Common Shares on a one-for-one basis upon the closing of the Issuer's initial public offering of Common Shares and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":26232},"source":{"system":"sec-edgar","filing":"0001628280-18-009511","document":"wf-form4_153237768270748.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1688757/000162828018009511/wf-form4_153237768270748.xml","form_type":"4"}},{"id":3862901,"issuer":{"id":4473,"kind":"organization","name":"ESTABLISHMENT LABS HOLDINGS INC."},"owners":[{"id":79070,"kind":"person","name":"COLLERAN LISA N","position":1,"cik":"0001212312","reported_name":"COLLERAN LISA N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2018-07-23T20:28:22.000Z","date":"2018-07-23","kind":"exercise","acquired":false,"shares":12699,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Class A Ordinary Shares automatically converted into Common Shares on a one-for-one basis upon the closing of the Issuer's initial public offering of Common Shares and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Class A Ordinary Shares automatically converted into Common Shares on a one-for-one basis upon the closing of the Issuer's initial public offering of Common Shares and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Class A Ordinary Shares automatically converted into Common Shares on a one-for-one basis upon the closing of the Issuer's initial public offering of Common Shares and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":12699},"source":{"system":"sec-edgar","filing":"0001628280-18-009511","document":"wf-form4_153237768270748.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1688757/000162828018009511/wf-form4_153237768270748.xml","form_type":"4"}},{"id":3862900,"issuer":{"id":4473,"kind":"organization","name":"ESTABLISHMENT LABS HOLDINGS INC."},"owners":[{"id":79070,"kind":"person","name":"COLLERAN LISA N","position":1,"cik":"0001212312","reported_name":"COLLERAN LISA N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2018-07-23T20:28:22.000Z","date":"2018-07-23","kind":"exercise","acquired":true,"shares":38931,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Class A Ordinary Shares automatically converted into Common Shares on a one-for-one basis upon the closing of the Issuer's initial public offering of Common Shares and had no expiration date."}],"balance_after":38931,"source":{"system":"sec-edgar","filing":"0001628280-18-009511","document":"wf-form4_153237768270748.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1688757/000162828018009511/wf-form4_153237768270748.xml","form_type":"4"}},{"id":3869737,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":79070,"kind":"person","name":"COLLERAN LISA N","position":1,"cik":"0001212312","reported_name":"COLLERAN LISA N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2018-07-11T21:05:56.000Z","date":"2018-07-09","kind":"grant","acquired":true,"shares":3916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Annual option grant for director of Issuer's Board of Directors, pro-rated for joining Board of Directors during annual period.  Option vests quarterly with all shares vested June 1, 2019 in conformity with vesting for such annual director grants."}],"balance_after":3916,"derivative":{"exercise_price":53.65,"expiration_date":"2028-07-09","underlying":"Common Stock","underlying_shares":3916},"source":{"system":"sec-edgar","filing":"0001179110-18-009630","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911018009630/edgar.xml","form_type":"4"}},{"id":3869736,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":79070,"kind":"person","name":"COLLERAN LISA N","position":1,"cik":"0001212312","reported_name":"COLLERAN LISA N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2018-07-11T21:05:56.000Z","date":"2018-07-09","kind":"grant","acquired":true,"shares":9134,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option grant for joining the Issuer's Board of Directors. Options vest quarterly as to 12.5% of total share amount beginning with the first vesting date on October 9, 2018 and becoming fully vested July 9, 2020 (two years after grant)."}],"balance_after":9134,"derivative":{"exercise_price":53.65,"expiration_date":"2028-07-09","underlying":"Common Stock","underlying_shares":9134},"source":{"system":"sec-edgar","filing":"0001179110-18-009630","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911018009630/edgar.xml","form_type":"4"}},{"id":3986568,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":79070,"kind":"person","name":"COLLERAN LISA N","position":1,"cik":"0001212312","reported_name":"COLLERAN LISA N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-21T21:56:43.000Z","date":"2018-03-19","kind":"grant","acquired":true,"shares":36281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The grant of these options is contingent upon shareholder approval of the 2018 Rockwell Medical, Inc. Long Term Incentive Plan (the \"2018 Plan\") at the Company's 2018 Annual Meeting of Shareholders.  If the Company's shareholders do not approve the 2018 Plan, these contingent options are deemed null and void and may not be exercised by the reporting person."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The grant of these options is contingent upon shareholder approval of the 2018 Rockwell Medical, Inc. Long Term Incentive Plan (the \"2018 Plan\") at the Company's 2018 Annual Meeting of Shareholders.  If the Company's shareholders do not approve the 2018 Plan, these contingent options are deemed null and void and may not be exercised by the reporting person."}],"balance_after":36281,"derivative":{"exercise_price":5.75,"exercise_date":"2019-03-19","expiration_date":"2028-03-19","underlying":"Common Stock","underlying_shares":36281},"source":{"system":"sec-edgar","filing":"0001140361-18-014500","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000114036118014500/doc1.xml","form_type":"4"}}]}